Harnessing antiviral memory to fight tumors: Redirected antibodies show promise
Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do not trigger especially strong anticancer immune resp…